Karen Douglas
Karen Douglas publishes mostly in Rheumatology, Cardiology and Cardiovascular Medicine and Nephrology, on topics such as Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research and Gout, Hyperuricemia, Uric Acid.
- World rank
- #524,734 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #45,457 of 367,258
- Works
- 132
- Citations
- 4.3k
- Citations per work
- 32.4
What does Karen Douglas research?
Karen Douglas's work is mostly in Medicine (51%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6751.1%
- Medicine6751.1%
- Everything else5743.0%
- Life Sciences85.9%
- 1Rheumatology30% of their works
- 2Cardiology and Cardiovascular Medicine6% of their works
- 3Nephrology6% of their works
- 4Immunology6% of their works
- 5Pathology and Forensic Medicine5% of their works
- 6Hematology4% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Gout, Hyperuricemia, Uric Acid
- Systemic Sclerosis and Related Diseases
- Spondyloarthritis Studies and Treatments
- Autoimmune and Inflammatory Disorders Research
- Biosimilars and Bioanalytical Methods
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Which keywords describe Karen Douglas's research?
The keywords of their largest research topics: Autoantibodies, Cardiovascular Risk, Inflammation, Biological Therapy, Rheumatoid Arthritis, Endothelial Dysfunction, Fibrosis and Antiphospholipid Syndrome.
- Immunogenicity
- Biosimilars
- Hemophagocytic Lymphohistiocytosis
- Ankylosing Spondylitis
- Systemic Sclerosis
- Hyperuricemia
- Antiphospholipid Syndrome
- Endothelial Dysfunction
- Biological Therapy
- Cardiovascular Risk
- Autoantibodies
- Inflammation
- Rheumatoid Arthritis
- Fibrosis
- Systemic Lupus Erythematosus
- Pulmonary Involvement
- Uric Acid
- Spondyloarthritis
- Juvenile Idiopathic Arthritis
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Autoantibodies1043 topics
- Cardiovascular Risk852 topics
- Inflammation852 topics
- Biological Therapy671 topic
- Rheumatoid Arthritis671 topic
- Endothelial Dysfunction362 topics
- Fibrosis242 topics
- Antiphospholipid Syndrome191 topic
- Systemic Lupus Erythematosus191 topic
- Hyperuricemia181 topic
- Pulmonary Involvement181 topic
- Systemic Sclerosis181 topic
- Uric Acid181 topic
- Ankylosing Spondylitis121 topic
- Spondyloarthritis121 topic
- Hemophagocytic Lymphohistiocytosis81 topic
- Juvenile Idiopathic Arthritis81 topic
- Biosimilars61 topic
- Idiopathic Pulmonary Fibrosis61 topic
- Immunogenicity61 topic
- Interstitial Lung Disease61 topic
Where does Karen Douglas work?
Karen Douglas's main affiliation in the publication record is Dudley Group NHS Foundation Trust, United Kingdom.
How many publications and citations does Karen Douglas have?
OpenAlex counts 132 works and 4,281 citations for Karen Douglas, an h-index of 37, ranking #524,734 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Karen Douglas. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.